search
Back to results

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

Primary Purpose

Diabetes Mellitus, Type 1

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard Carb Diet
Low Carb Diet
Sponsored by
Vanderbilt University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 1 focused on measuring low carbohydrate diet, hyperinsulinemia, insulin resistance, endothelial dysfunction, vascular health

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age: 18-60
  • HbA1c: 5.6-9.0%
  • Insulin delivery: must be on an insulin pump
  • Glucose Monitor: must use a continuous glucose monitor (CGM)
  • BMI 18-33 kg/m^2
  • Body Mass >/= 50 kg ( 110 lbs)

Exclusion Criteria:

  • severe hypoglycemia : >/= 1 episode in the past 3 months
  • diabetes comorbidities (>= 1 trip to emergency department for poor glucose control in the past 6 months,
  • New York Heart Association Class II-IV cardiac functional status
  • SBP > 140 and DBP > 100 mmHg,
  • eGFR by MDRD equation of <60 mL/min/1.73m^2
  • AST or ALT > 2.5 times the upper limit of normal
  • HCT <35%

medications

  • any antioxidant vitamin supplement (<2 weeks before STUDY visit)
  • any systemic glucocorticoid
  • any antipsychotic
  • atenolol, metoprolol, propranolol
  • niacin
  • any thiazide diuretic
  • any OCP with > 35 mcg ethinyl estradiol,
  • growth hormone
  • any immunosuppressant
  • any antihypertensive
  • any antihyperlipidemic

other:

  • pregnancy
  • Tanner stage < 5
  • peri or postmenopausal woman
  • active smoker
  • gluten-free diet requirement

Additional exclusion criteria for T1DM subjects

  • any diabetes medication except insulin

Sites / Locations

  • Vanderbilt University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Standard Carb Diet then Low Carb Diet

Low Carb Diet then Standard Carb Diet

Arm Description

Outcomes

Primary Outcome Measures

Change in insulin sensitivity - diet 1
Change in insulin sensitivity based on diet
Change in insulin sensitivity - diet 2
Change in insulin sensitivity based on diet
Change in endothelial function - diet 1
will quantify brachial artery, endothelium-dependent flow-mediated vasodilation using high-resolution ultrasound
Change in endothelial function - diet 2
will quantify brachial artery, endothelium-dependent flow-mediated vasodilation using high-resolution ultrasound

Secondary Outcome Measures

Full Information

First Posted
October 2, 2019
Last Updated
August 14, 2023
Sponsor
Vanderbilt University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04118374
Brief Title
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
Official Title
A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 29, 2019 (Actual)
Primary Completion Date
February 28, 2024 (Anticipated)
Study Completion Date
February 28, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators will test the hypothesis that reducing insulin doses using a low carbohydrate diet (LCD) will be associated with with improved insulin sensitivity (Aim 1) and blood vessel health (Aim 2).
Detailed Description
Insulin resistance (IR) is consistently found in patients with type 1 diabetes (T1DM) and pathophysiologically links T1DM with atherosclerotic disease. IR and nascent atherosclerosis, as characterized by endothelial dysfunction, are present early in T1DM. Although atherosclerosis leads to cardiovascular disease (CVD)-the predominant cause of death in T1DM-the early cardiometabolic processes driving atherosclerosis are not currently well-characterized. My overarching hypothesis is that IR and endothelial dysfunction in T1DM are, in part, iatrogenic, occurring as a function of nonphysiologic insulin delivery. Previous research shows IR in T1DM is closely related to iatrogenic hyperinsulinemia. Iatrogenic hyperinsulinemia in T1DM results from injecting insulin into subcutaneous tissue rather than delivering insulin more physiologically into the hepatic portal vein. Hyperinsulinemia, per se, is closely linked with IR and independently predicts CVD in diabetic and nondiabetic populations. Thus, peripheral insulin delivery brings about unintended adverse cardiometabolic consequences in T1DM. The investigators propose a practical intervention to diminish iatrogenic hyperinsulinemia and thereby mitigate CVD risk. The investigators hypothesize that a reduction in iatrogenic hyperinsulinemia brought about by a low carbohydrate diet (LCD) will independently correlate with improved insulin sensitivity (Aim 1) and endothelial function (Aim 2). In this pilot study, the investigators will mechanistically dissect the contribution of iatrogenic hyperinsulinemia to IR and endothelial dysfunction in 8 adults with T1DM using a crossover study of LCD vs. standard carbohydrate diet (SCD) to experimentally modify hyperinsulinemia. The investigators will quantify insulin sensitivity using hyperinsulinemic, euglycemic clamps and measure endothelium-dependent flow mediated vasodilation using high-resolution ultrasound.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 1
Keywords
low carbohydrate diet, hyperinsulinemia, insulin resistance, endothelial dysfunction, vascular health

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard Carb Diet then Low Carb Diet
Arm Type
Experimental
Arm Title
Low Carb Diet then Standard Carb Diet
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Standard Carb Diet
Intervention Description
Approximately 50% of caloric intake will come from carbohydrate consumption.
Intervention Type
Other
Intervention Name(s)
Low Carb Diet
Intervention Description
Approximately 25% of caloric intake will come from carbohydrate consumption.
Primary Outcome Measure Information:
Title
Change in insulin sensitivity - diet 1
Description
Change in insulin sensitivity based on diet
Time Frame
baseline to 1 week
Title
Change in insulin sensitivity - diet 2
Description
Change in insulin sensitivity based on diet
Time Frame
baseline to 1 week
Title
Change in endothelial function - diet 1
Description
will quantify brachial artery, endothelium-dependent flow-mediated vasodilation using high-resolution ultrasound
Time Frame
baseline to 1 week
Title
Change in endothelial function - diet 2
Description
will quantify brachial artery, endothelium-dependent flow-mediated vasodilation using high-resolution ultrasound
Time Frame
baseline to 1 week

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age: 18-60 HbA1c: 5.6-9.0% Insulin delivery: must be on an insulin pump Glucose Monitor: must use a continuous glucose monitor (CGM) BMI 18-33 kg/m^2 Body Mass >/= 50 kg ( 110 lbs) Exclusion Criteria: severe hypoglycemia : >/= 1 episode in the past 3 months diabetes comorbidities (>= 1 trip to emergency department for poor glucose control in the past 6 months, New York Heart Association Class II-IV cardiac functional status SBP > 140 and DBP > 100 mmHg, eGFR by MDRD equation of <60 mL/min/1.73m^2 AST or ALT > 2.5 times the upper limit of normal HCT <35% medications any antioxidant vitamin supplement (<2 weeks before STUDY visit) any systemic glucocorticoid any antipsychotic atenolol, metoprolol, propranolol niacin any thiazide diuretic any OCP with > 35 mcg ethinyl estradiol, growth hormone any immunosuppressant any antihypertensive any antihyperlipidemic other: pregnancy Tanner stage < 5 peri or postmenopausal woman active smoker gluten-free diet requirement Additional exclusion criteria for T1DM subjects any diabetes medication except insulin
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
T. Jordan Smith, RN, BSN
Phone
615-936-6324
Email
metabolism@vumc.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Justin M Gregory, MD, MSCI
Organizational Affiliation
Vanderbilt University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37232
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
T. Jordan Smith, RN, BSN
Phone
615-936-6324
Email
metabolism@vumc.org
First Name & Middle Initial & Last Name & Degree
Justin M Gregory, MD, MSCI

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The datasets generated during and/or analyzed during the current study can be available from the corresponding author upon reasonable request. Data sets can be made available beginning 3 months and ending 5 years following article publication. No applicable resources have yet been generated or analyzed during the current study.

Learn more about this trial

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

We'll reach out to this number within 24 hrs